NCT00018343CompletedPhase 2
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Locations
- 1
Study Overview
Brief Summary
This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 50 Years to 90 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Post menopausal women with alzheimer's disease
- •free of any major medical or neurological disease,
- •medically safe to be treated with estrogen.
Exclusion Criteria
- Not provided
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Alzheimer's Disease: Therapeutic Potential of EstrogenAlzheimer DiseaseNCT00066157University of Wisconsin, Madison42
Completed
Phase 3
Alzheimer's Disease Prevention TrialAlzheimer DiseaseMemory DisordersNCT00000176National Institute on Aging (NIA)
Completed
Not Applicable
Estrogen Use in Protection From Cognitive DeclineAgingMenopauseNCT00097058Stanford University71
Recruiting
Not Applicable
Hormone Replacement Trial Against ALzheimers' DiseaseAlzheimer DiseasePostmenopausal SymptomsNCT04312399University Hospital, Ghent600
Unknown
Phase 2
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal WomenMenopauseNCT00005768National Center for Research Resources (NCRR)